Therapeutic modification of nuclear factor κB binding activity and tumor necrosis factor-α gene expression during acute biliary pancreatitis

American Surgeon

Volumn 63, Issue 12, 1997, Pages 1036-1044

  Dunn, Julie A ^a   Li, Chuanfu ^a   Ha, Tuanzhu ^a   Kao, Race L ^a   Browder, William ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOBARBITAL; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; GENE CONTROL; GENE THERAPY; INFLAMMATION; NONHUMAN; PANCREATITIS; PATHOGENESIS; RAT;

ACUTE DISEASE; AMOBARBITAL; AMYLASES; ANIMALS; BILIRUBIN; CHOLESTASIS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GABA MODULATORS; GENE EXPRESSION; MALE; NF-KAPPA B; PANCREATIC DUCTS; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030730967     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Grewal HP, Mohey El D, Kotb M, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction following hepatic passage. Surgery 1994;115:213-21.
2. McKay C, Gallagher G, Baxter JW, et al. Systemic complications in acute pancreatitis are associated with increased monocyte release. Gut 1994;35:575.
3. Hughes C, Gaber LW, El-Din ABM, et al. Inhibition of TNF-α improves survival in an experimental model of acute pancreatitis. Am Surg 1996;62:8-13.
4. Streiter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993;21:8447-63.
5. Dominquez-Munoz JE, Viedma JA, Perez-Mateo M, et al. Inflammatory response in the initial phase of acute pancreatitis: Relationship to the onset and severity of the disease. Rev Exp Enf Digest 1995;87:225-35.
6. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1994;117:648-55.
7. Norman JG, Fink GW, Messina J, et al. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996;120:515-21.
8. Schoenberg MH, Buchler M, Beger HG. Oxygen radicals in experimental acute pancreatitis. Hepato-Gastroenterol 1994;41: 313-9.
9. Gough DB, Boyle B, Joyce WP, et al. Free radical inhibition and serial chemiluminescence in evolving experimental pancreatitis. Br J Surg 1990;77:1256-9.
10. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996;10:709-20.
11. Schulze-Osthoff K, Beyaert R, Vandervoorde V, et al. Depletion of mitochondrial electron transport abrograted the cytotoxic and gene-inductive effects of TNF. EMBO J 1993;12: 3095-104.
12. Fiers W. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991;285:199-212.
13. Azima B, Kao RL, Youngberg G, et al. A new model of reversible acute pancreatitis. J Surg Res 1996;63:419-24.
14. Schreiber EP, Mattias P, Muller MM, et al. Rapid detection of octamer binding proteins in "mini-extracts" prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
15. Buchler M, Friess H, Uhl W, et al. Clinical relevance of experimental acute pancreatitis. Eur Surg Res 1992;24:85-8.
16. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis. Hepato-Gastroenterol 1993;40:522-30.
17. Echternacher G, Falk W, Mannel DN, et al. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990;145:3762-6.
18. Grewal HP, El-Din AM, Gaber L. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-α polyclonal antibody. Am J Surg 1994;167:214-9.
19. Fisher C, Opal SM, Dhainaut JF, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Grit Care Med 1993;21:318-27.
20. Exley AR, Cohen J, Buurman W, et al. Monoclonal antibody to TNF in severe septic shock. Lancet 1990;3325:1275-7.
21. Guice KS, Oldham KT, Remick DG, et al. Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced pancreatitis. J Surg Res 1991;51:495-9.
22. Formela CJ, Galloway SW, Kingsworth AN. Inflammatory mediators in acute pancreatitis. Br J Surg 1995;82:6-13.
23. Schoenberg MH, Buchler M, Gasper M, et al. The involvement of oxygen radicals in acute pancreatitis. Gut 1990;31:1138-43.
24. Niederau C, Niederau M, Borchard F. Effects of antioxidants and free radical scavengers in three different models of acute pancreatitis. Pancreas 1992;7:486-96.
25. Steer ML, Rutledge PL, Powers RE. The role of oxygen-derived free radicals in two models of experimental acute pancreatitis: Effects of catalase, superoxide dismutase, dimethylsulfoxide, and allopurinol. Klin Wochenschr 1991;69:1012-7.
26. Karakurum M, Shrieniwas R, Chen J, et al. Hypoxic induction of Interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994;93:1564-70.
27. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
28. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκBα on tyrosine residues. Cancer Res 1994;54:1425-30.